|
1
|
Wang X, Yang B and Ma B: The
UCA1/miR-204/Sirt1 axis modulates docetaxel sensitivity of prostate
cancer cells. Cancer Chemother Pharmacol. 78:1025–1031. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Byles V, Zhu L, Lovaas JD, Chmilewski LK,
Wang J, Faller DV and Dai Y: SIRT1 induces EMT by cooperating with
EMT transcription factors and enhances prostate cancer cell
migration and metastasis. Oncogene. 31:4619–4629. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu Y, Liu P, Zheng DH, Wu N, Zhu L, Xing C
and Zhu J: Expression profile and prognostic value of NNMT in
patients with pancreatic cancer. Oncotarget. 7:19975–19981.
2016.PubMed/NCBI
|
|
4
|
Zhou W, Gui M, Zhu M, Long Z, Huang L,
Zhou J, He L and Zhong K: Nicotinamide N-methyltransferase is
overexpressed in prostate cancer and correlates with prolonged
progression-free and overall survival times. Oncol Lett.
8:1175–1180. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chlopicki S, Kurdziel M, Sternak M,
Szafarz M, Szymura-Oleksiak J, Kamiński K and Żołądź JA: Single
bout of endurance exercise increases NNMT activity in the liver and
MNA concentration in plasma; the role of IL-6. Pharmacol Rep.
64:369–376. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sartini D, Pozzi V, Renzi E, Morganti S,
Rocchetti R, Rubini C, Santarelli A, Lo Muzio L and Emanuelli M:
Analysis of tissue and salivary nicotinamide N-methyltransferase in
oral squamous cell carcinoma: Basis for the development of a
noninvasive diagnostic test for early-stage disease. Biol Chem.
393:505–511. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sartini D, Muzzonigro G, Milanese G, Pozzi
V, Vici A, Morganti S, Rossi V, Mazzucchelli R, Montironi R and
Emanuelli M: Upregulation of tissue and urinary nicotinamide
N-methyltransferase in bladder cancer: Potential for the
development of a urine-based diagnostic test. Cell Biochem Biophys.
65:473–483. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pissios P: Nicotinamide
N-Methyltransferase: More than a vitamin B3 clearance enzyme.
Trends Endocrinol Metab. 28:340–353. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hong S, Moreno-Navarrete JM, Wei X,
Kikukawa Y, Tzameli I, Prasad D, Lee Y, Asara JM, Fernandez-Real
JM, Maratos-Flier E and Pissios P: Nicotinamide N-methyltransferase
regulates hepatic nutrient metabolism through Sirt1 protein
stabilization. Nat Med. 21:887–894. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cui Y, Li J, Zheng F, Ouyang Y, Chen X,
Zhang L, Chen Y, Wang L, Mu S and Zhang H: Effect of SIRT1 gene on
Epithelial-mesenchymal transition of human prostate cancer PC-3
cells. Med Sci Monit. 22:380–386. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Duan K, Ge YC, Zhang XP, Wu SY, Feng JS,
Chen SL, Zhang LI, Yuan ZH and Fu CH: miR-34a inhibits cell
proliferation in prostate cancer by downregulation of SIRT1
expression. Oncol Lett. 10:3223–3227. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hoffmann MJ, Engers R, Florl AR, Otte AP,
Muller M and Schulz WA: Expression changes in EZH2, but not in
BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation
changes in prostate cancer. Cancer Biol Ther. 6:1403–1412. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jung-Hynes B and Ahmad N: Role of p53 in
the anti-proliferative effects of Sirt1 inhibition in prostate
cancer cells. Cell Cycle. 8:1478–1483. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nakane K, Fujita Y, Terazawa R, Atsumi Y,
Kato T, Nozawa Y, Deguchi T and Ito M: Inhibition of cortactin and
SIRT1 expression attenuates migration and invasion of prostate
cancer DU145 cells. Int J Urol. 19:71–79. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cheng L, Montironi R, Bostwick DG,
Lopez-Beltran A and Berney DM: Staging of prostate cancer.
Histopathology. 60:87–117. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang BD, Ceniccola K, Hwang S, Andrawis R,
Horvath A, Freedman JA, Olender J, Knapp S, Ching T, Garmire L, et
al: Alternative splicing promotes tumour aggressiveness and drug
resistance in African American prostate cancer. Nat Commun.
8:159212017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Trammell SA and Brenner C: NNMT: A bad
actor in fat makes good in liver. Cell Metab. 22:200–201. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Palanichamy K, Kanji S, Gordon N,
Thirumoorthy K, Jacob JR, Litzenberg KT, Patel D and Chakravarti A:
NNMT silencing activates tumor suppressor PP2A, inactivates
oncogenic STKs, and inhibits tumor forming ability. Clin Cancer
Res. 23:2325–2334. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xie X, Liu H, Wang Y, Zhou Y, Yu H, Li G,
Ruan Z, Li F, Wang X and Zhang J: Nicotinamide N-methyltransferase
enhances resistance to 5-fluorouracil in colorectal cancer cells
through inhibition of the ASK1-p38 MAPK pathway. Oncotarget.
7:45837–45848. 2016.PubMed/NCBI
|
|
21
|
Win KT, Lee SW, Huang HY, Lin LC, Lin CY,
Hsing CH, Chen LT and Li CF: Nicotinamide N-methyltransferase
overexpression is associated with Akt phosphorylation and indicates
worse prognosis in patients with nasopharyngeal carcinoma. Tumour
Biol. 34:3923–3931. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu T, Wang YT, Chen P, Li YH, Chen YX,
Zeng H, Yu AM, Huang M and Bi HC: Effects of nicotinamide
N-methyltransferase on PANC-1 cells proliferation, metastatic
potential and survival under metabolic stress. Cell Physiol
Biochem. 35:710–721. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu T, Liu PY and Marshall GM: The
critical role of the class III histone deacetylase SIRT1 in cancer.
Cancer Res. 69:1702–1705. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yamamoto H, Schoonjans K and Auwerx J:
Sirtuin functions in health and disease. Mol Endocrinol.
21:1745–1755. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lovaas JD, Zhu L, Chiao CY, Byles V,
Faller DV and Dai Y: SIRT1 enhances matrix metalloproteinase-2
expression and tumor cell invasion in prostate cancer cells.
Prostate. 73:522–530. 2013. View Article : Google Scholar : PubMed/NCBI
|
